U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Pemigatinib (Pemazyre): CADTH Reimbursement Recommendation: Indication: For the treatment of adults with previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma with a FGFR2 fusion or other rearrangement [Internet].

Pemigatinib (Pemazyre): CADTH Reimbursement Recommendation: Indication: For the treatment of adults with previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma with a FGFR2 fusion or other rearrangement [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Apr.

Table of contents


Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...